Literature DB >> 1185596

Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine.

S Wilk, E Watson, M E Stanley.   

Abstract

The mechanisms underlying the dissociation of the extrapyramidal and antipsychotic properties of haloperidol as compared to clozapine were explored by studying the effects of these drugs on dopamine metabolism in the straitum and tuberculum olfactorium (TO) of the rat. Homovanillic acid and 3,4-dihydroxyphenylacetic acid were simutaneously measured in these regions by a gas chromatographic techinque after treating the rats with different doses of the drugs. Dose-response curves and time-action curves were generated. For both drugs, a higher dose was required to achieve half-maximal metabolite elevation in the TO as compared to the striatum. The apparent differential sensitivity to haloperidol was attributed to differences in time to peak response. The time to peak response to clozapine was similar in both structures. Thus, the striatum appears to be more sensitive to clozapine than the TO with respect to elevation of dopamine metabolites. The effect of haloperidol on dopamine metabolism in the striatum was more persistent than that in the TO. After 4 hours, metabolite levels were still elevated in the striatum, whereas after 2 hours they returned to base line in the TO. The extrapyramidal effects of haloperidol may be due to the persistent action of this drug on dopamine metabolism in the striatum, and the lack of extrapyramidal effects of clozapine may be due to its brief action on dopamine metabolism in the striatum.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1185596

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  18 in total

Review 1.  Basic biology of clozapine: electrophysiological and neuroendocrinological studies.

Authors:  G A Gudelsky; J F Nash; S A Berry; H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 2.  Clozapine--pharmacokinetic investigations and biochemical effects in man.

Authors:  M Ackenheil
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: evidence for two different mechanisms of action.

Authors:  T Ljungberg; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1978-04-11       Impact factor: 4.530

4.  Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics.

Authors:  A S Undie; E Friedman
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Effects of clozapine on CSF homovanillic acid in spasmodic torticollis.

Authors:  A Thiel; D Dressler; A Reimer; E Rüther
Journal:  J Neural Transm Gen Sect       Date:  1994

6.  Genetic regulation of neurotransmitter enzymes and receptors: relationship to the inheritance of psychiatric disorders.

Authors:  R D Ciaranello; R E Boehme
Journal:  Behav Genet       Date:  1982-02       Impact factor: 2.805

7.  Modulation of reward and aversion processes in the rat diencephalon by neuroleptics: differential effects of clozapine and haloperidol.

Authors:  D M Atrens; T Ljungberg; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1976-08-26       Impact factor: 4.530

Review 8.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Authors:  A Fitton; R C Heel
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

9.  Localization of the site of the haloperidol-induced, prolactin-mediated increase of dopamine turnover in the median eminence: studies in rats with complete hypothalamic deafferentations.

Authors:  G A Gudelsky; L Annunziato; K E Moore
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

10.  Modulating role of lithium on dopamine turnover, prolactin release, and behavioral supersensitivity following haloperidol and reserpine.

Authors:  I M McIntyre; C Kuhn; S Demitriou; F R Fucek; M Stanley
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.